Pfizer Free Cash Flow 2010-2024 | PFE

Pfizer free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Pfizer annual free cash flow for 2024 was $9.835B, a 105.2% increase from 2023.
  • Pfizer annual free cash flow for 2023 was $4.793B, a 81.59% decline from 2022.
  • Pfizer annual free cash flow for 2022 was $26.031B, a 12.85% decline from 2021.

Pfizer Free Cash Flow 2010-2024 | PFE

  • Pfizer annual free cash flow for 2024 was $9.835B, a 105.2% increase from 2023.
  • Pfizer annual free cash flow for 2023 was $4.793B, a 81.59% decline from 2022.
  • Pfizer annual free cash flow for 2022 was $26.031B, a 12.85% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B